Andrea Nozza

Rozzano, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Regular assessment of serum vascular endothelial growth factor levels to monitor POEMS syndrome.

Regular assessment of serum vascular endothelial growth factor levels to monitor POEMS syndrome.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: June 29, 2023

Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse.

Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse.

Journal: British journal of haematology

Published: July 04, 2019

Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers.

Peripheral Blood Hemopoietic Stem Cell Mobilization Regimens in POEMS Syndrome: A Retrospective Study at 2 Hematologic Italian Centers.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: May 03, 2019

Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP program.

Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP program.

Journal: Hematological oncology

Published: April 30, 2018

Clinical, electrophysiological and VEGF 2-year response after lenalidomide or stem cell transplantation in patients with POEMS syndrome.

Clinical, electrophysiological and VEGF 2-year response after lenalidomide or stem cell transplantation in patients with POEMS syndrome.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: January 03, 2018

Advances in the Treatment of Paraproteinemic Neuropathy.

Advances in the Treatment of Paraproteinemic Neuropathy.

Journal: Current treatment options in neurology

Published: October 17, 2017

Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous Transplantation.

Long-Term Follow-Up of a Donor versus No-Donor Comparison in Patients with Multiple Myeloma in First Relapse after Failing Autologous Transplantation.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: August 04, 2017

Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.

Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.

Journal: British journal of haematology

Published: June 09, 2017

POEMS SYNDROME: an Update.

POEMS SYNDROME: an Update.

Journal: Mediterranean journal of hematology and infectious diseases

Published: May 26, 2017

Bendamustine in relapsed/refractory multiple myeloma: the "real-life" side of the moon.

Bendamustine in relapsed/refractory multiple myeloma: the "real-life" side of the moon.

Journal: Leukemia & lymphoma

Published: February 05, 2015

Transcranial direct current stimulation (tDCS) and lymphocytes.

Transcranial direct current stimulation (tDCS) and lymphocytes.

Journal: Brain stimulation

Published: October 01, 2013

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.

Journal: Blood

Published: April 14, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026